Javascript must be enabled to continue!
A Vascularized Tumoroid Model for Human Glioblastoma Angiogenesis
View through CrossRef
Glioblastoma (GBM) angiogenesis is critical for tumor growth and recurrence, making it a compelling therapeutic target. Here, a disease-relevant, vascularized tumoroidin vitromodel with stem-like features and stromal surrounds is reported. The model is used to recapitulate how individual components of the GBM’s complex brain microenvironment such as hypoxia, vasculature-related stro-mal cells and growth factors support GBM angiogenesis. It is scalable, tractable, cost-effective and can be used with biologically-derived or biomimetic matrices. Patient-derived primary GBM cells are found to closely participate in blood vessel formation in contrast to a GBM cell line containing differentiated cells. Exogenous growth factors amplify this effect under normoxia but not at hypoxia suggesting that a significant amount of growth factors is already being produced under hypoxic conditions. Under hypoxia, primary GBM cells and umbilical vein endothelial cells are found to strongly co-localize in a mosaic pattern to form sprouting vascular networks, with GBM cells acquiring an endothelial-like behaviour, which has been reported to occurin vivo. These findings demonstrate that our 3D tumoroidin vitromodel exhibits biomimetic attributes that may permit its use as a preclinical model in studying microenvironment cues of tumor angiogenesis.
Cold Spring Harbor Laboratory
Title: A Vascularized Tumoroid Model for Human Glioblastoma Angiogenesis
Description:
Glioblastoma (GBM) angiogenesis is critical for tumor growth and recurrence, making it a compelling therapeutic target.
Here, a disease-relevant, vascularized tumoroidin vitromodel with stem-like features and stromal surrounds is reported.
The model is used to recapitulate how individual components of the GBM’s complex brain microenvironment such as hypoxia, vasculature-related stro-mal cells and growth factors support GBM angiogenesis.
It is scalable, tractable, cost-effective and can be used with biologically-derived or biomimetic matrices.
Patient-derived primary GBM cells are found to closely participate in blood vessel formation in contrast to a GBM cell line containing differentiated cells.
Exogenous growth factors amplify this effect under normoxia but not at hypoxia suggesting that a significant amount of growth factors is already being produced under hypoxic conditions.
Under hypoxia, primary GBM cells and umbilical vein endothelial cells are found to strongly co-localize in a mosaic pattern to form sprouting vascular networks, with GBM cells acquiring an endothelial-like behaviour, which has been reported to occurin vivo.
These findings demonstrate that our 3D tumoroidin vitromodel exhibits biomimetic attributes that may permit its use as a preclinical model in studying microenvironment cues of tumor angiogenesis.
Related Results
Abstract 2047: Scale up and scale down approaches for screening of 3D patient-derived cell models
Abstract 2047: Scale up and scale down approaches for screening of 3D patient-derived cell models
Abstract
3D cell culture is becoming more prevalent as scientists work to better model human physiology using in vitro systems. However, differences in handling 3D c...
A vascularized tumoroid model for human glioblastoma angiogenesis
A vascularized tumoroid model for human glioblastoma angiogenesis
AbstractGlioblastoma (GBM) angiogenesis is critical for tumor growth and recurrence, making it a compelling therapeutic target. Here, a disease-relevant, vascularized tumoroid in v...
Abstract 2750: Multiplexed plate-reader based drug screening of 3D-tumoroid models
Abstract 2750: Multiplexed plate-reader based drug screening of 3D-tumoroid models
Abstract
Cancer drug development is an extremely challenging and resource-consuming process with a dismal success rate of 5%. The high failure rate is partly due to ...
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract
Background: The standard therapy for glioblastoma patients is tumor resection followed by radiotherapy and temozolomide chemotherapy. Although glioblastoma ...
Advancements in diagnosis and treatment of Adenomyosis
Advancements in diagnosis and treatment of Adenomyosis
In this thesis, we aimed to study how we can improve the diagnosing of adenomyosis by imaging the uterus in part I, especially using ultrasound and considering the assessment of th...
Biphasic Effects of Statins on Angiogenesis-Mediated Processes.
Biphasic Effects of Statins on Angiogenesis-Mediated Processes.
Abstract
Background: Statins inhibit HMG-CoA reductase, resulting in the reduction of cholesterol synthesis as well as isoprenoids that modulate various cell functio...
Abstract 1226: Advancing CAR-T cell therapies using Nilogen’s ex vivo 3D tumoroid platform
Abstract 1226: Advancing CAR-T cell therapies using Nilogen’s ex vivo 3D tumoroid platform
Abstract
Background:
Advancing CAR-T cell therapies for solid tumors remain a significant challenge due to the complexities of t...
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Abstract
Background: During brain development, chemical cues released by developing neurons, cellular signaling with pericytes, and mechanical cues within the brain extrace...

